Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPATA6 encodes a structural protein that plays a critical role in the development of the sperm connecting piece, linking the sperm head to the flagellum during late spermiogenesis[2]. This protein is highly conserved across vertebrates and is expressed exclusively in haploid germ cells (spermatids and spermatozoa)[1][2][3]. It is involved in microfilament transport via interactions with myosin subunits and is essential for male fertility; deficiency leads to acephalic spermatozoa (sperm without heads) and subsequent infertility[2][3]. In testicular germ cell tumor models, downregulation of SPATA6 is associated with reduced cell viability and enhanced apoptosis, suggesting a possible role in tumor cell survival and a potential target for cancer therapy[1]. No approved drugs directly target SPATA6, but its tissue- and development-specific expression makes it an important candidate for biomarker development in reproductive medicine[1][2][3].
Not applicable at present (no drugs targeting SPATA6); experimental RNA interference decreases cell viability and increases apoptosis in cell models
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogenesis-associated protein 6 (SPATA6).